Skip to main content

J&J Wins California Trial Linked To Talc-Cancer Claim

J&J Wins California Trial Linked To Talc-Cancer Claim

J&J Wins California Trial Linked To Talc-Cancer Claim

Introduction

On Friday, April 5, a jury in Long Beach, California, rejected a talcum powder lawsuit brought by a 65-year-old retired teacher, who claimed that Johnson & Johnson's baby powder was contaminated with asbestos and was the reason for his cancer.

The plaintiff who used J&J’s baby powder daily for personal hygiene was diagnosed with mesothelioma in July 2017, and he blamed asbestos exposure from the talcum powder for his disease and filed a complaint two months later. At the end of the five-week trial, the jury returned a unanimous verdict in favor of J&J Consumer Inc., rejecting the plaintiff’s claims. The talcum giant asserted that its baby powder was free from asbestos and did not cause the plaintiff’s disease. The plaintiff's attorney confirmed the jury verdict and told they still believe J&J's talc-based products are contaminated with asbestos, considering the hundreds of historical test results proving the presence of carcinogens in its talc. The verdict came in a week after the company settled three similar cases linked to its baby powder and a rare form of cancer, mesothelioma. Two of those cases were settled during their trial in Oklahoma and California, and another one in New York was settled just less than two weeks before the trial.

There are more than 13,000 lawsuits filed against J&J linking its talc products to ovarian cancer or mesothelioma. The company will face more than two dozen trials in different U.S. courts this year.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!